Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001415889-25-013210·Kura Oncology, Inc.
Schedule 13G ownership disclosure
Kura Oncology Inc
Common Stock, par value $0.0001 per share · CUSIP: 50127T109
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 4,004,610.00 · Class: 4.9%
- Peter Kolchinsky
Shares: 4,004,610.00 · Class: 4.9%
- Rajeev Shah
Shares: 4,004,610.00 · Class: 4.9%
- RA Capital Healthcare Fund, L.P.
Shares: 4,004,610.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-013210
- Form type
- SCHEDULE 13G/A
- Filer
- Kura Oncology, Inc.
- CIK
- CIK 1422143
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership